Chakder S, Rattan S
Division of Gastroenterology and Hepatology, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Am J Physiol. 1998 Oct;275(4):G769-77. doi: 10.1152/ajpgi.1998.275.4.G769.
Despite its widespread distribution and significance in the gut, the role of pituitary adenylate cyclase-activating peptide (PACAP) in internal anal sphincter (IAS) relaxation has not been examined. This study examined the role of PACAP in nonadrenergic noncholinergic (NANC) nerve-mediated relaxation of IAS smooth muscle. Circular smooth muscle strips from the opossum IAS were prepared for measurement of isometric tension. The influence of PACAP and vasoactive intestinal peptide (VIP) antagonists and tachyphylaxis on the neurally mediated IAS relaxation was examined either separately or in combination. The release of these neuropeptides in response to NANC nerve stimulation before and after the nitric oxide (NO) synthase inhibitor Nomega-nitro-L-arginine and NO was also investigated. Both PACAP and VIP antagonists caused significant attenuation of IAS relaxation by NANC nerve stimulation. The combination of the antagonists, however, did not have an additive effect on IAS relaxation. VIP tachyphylaxis caused significant suppression of IAS relaxation by NANC nerve stimulation. PACAP and VIP were found to be released by NANC nerve stimulation and exogenous NO. The data suggest the involvement of PACAP in IAS relaxation primarily by the activation of PACAP1/VIP receptor and lack of its independent role in the relaxation. Furthermore, NO may regulate the presynaptic release of PACAP and VIP.
尽管垂体腺苷酸环化酶激活肽(PACAP)在肠道中分布广泛且具有重要意义,但其在肛门内括约肌(IAS)舒张中的作用尚未得到研究。本研究探讨了PACAP在非肾上腺素能非胆碱能(NANC)神经介导的IAS平滑肌舒张中的作用。制备了负鼠IAS的环形平滑肌条以测量等长张力。分别或联合研究了PACAP和血管活性肠肽(VIP)拮抗剂以及快速耐受性对神经介导的IAS舒张的影响。还研究了在一氧化氮(NO)合酶抑制剂Nω-硝基-L-精氨酸和NO处理前后,这些神经肽对NANC神经刺激的反应释放情况。PACAP和VIP拮抗剂均导致NANC神经刺激引起的IAS舒张显著减弱。然而,拮抗剂的联合使用对IAS舒张没有相加作用。VIP快速耐受性导致NANC神经刺激引起的IAS舒张显著抑制。发现NANC神经刺激和外源性NO可释放PACAP和VIP。数据表明,PACAP主要通过激活PACAP1/VIP受体参与IAS舒张,且在舒张中缺乏独立作用。此外,NO可能调节PACAP和VIP的突触前释放。